<DOC>
	<DOCNO>NCT01525199</DOCNO>
	<brief_summary>The purpose trial compare evolution patient receive first line treatment locally advance metastatic lung cancer , take account request EGFR mutation test part diagnosis treatment strategy . There assignment particular therapeutic strategy .</brief_summary>
	<brief_title>Diagnosis Treatment Strategies Patients With NSCLC With Without EGFR Mutations .</brief_title>
	<detailed_description>Study case control diagnosis treatment strategy patient NSCLC without EGFR mutation .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Patients confirm diagnosis lung adenocarcinoma , stage IIIb/IV . Patients 1st line treatment lung adenocarcinoma . Patients information require protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Non-Small Cell Lung Cancer ,</keyword>
	<keyword>Epidermal Growth Factor Receptor mutation ,</keyword>
	<keyword>Lung cancer ,</keyword>
	<keyword>Lung adenocarcinoma</keyword>
</DOC>